ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

SEHK:1541 Stock Report

Market Cap: HK$4.7b

ImmuneOnco Biopharmaceuticals (Shanghai) Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1541?
Owner TypeNumber of SharesOwnership Percentage
Private Companies2,185,0200.584%
Employee Share Scheme48,356,95512.9%
VC/PE Firms61,597,93516.5%
Individual Insiders71,691,67019.2%
General Public93,073,70024.9%
Institutions97,252,41526%

Dilution of Shares: 1541 only recently listed within the past 12 months


Top Shareholders

Top 15 shareholders own 75.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.8%
Tian Wenzhi
70,182,990HK$874.5m0%no data
12.9%
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. , ESOP
48,356,955HK$602.5m0%no data
11.3%
Shanghai Yongkan Investment Management Co., Ltd.
42,334,695HK$527.5m0%no data
5.15%
Lapam Capital
19,263,240HK$240.0m0%19.67%
4.28%
Lyfe Capital
16,011,675HK$199.5m0%26.04%
4.06%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
15,178,770HK$189.1m0%4.22%
3.86%
Shanghai Liyi Investment Management Partnership (Limited Partnership)
14,428,170HK$179.8m0%15.4%
3.7%
Greater Bay Area Homeland Investments Limited
13,854,690HK$172.6m0%95.77%
3.35%
LAV Investment Adviser Limited
12,542,805HK$156.3m0%no data
2.9%
Shanghai Zhangjiang Science&Technology Venture Capital Co., Ltd
10,862,055HK$135.3m0%32.48%
2.57%
Shanghai Milestone Asset Management Co., Ltd.
9,631,620HK$120.0m0%21.04%
1.27%
Shanghai Lineng Asset Management Co., Ltd.
4,742,630HK$59.1m0%29.34%
0.58%
Milestone Asset Management (Cayman) Co., Ltd.
2,185,020HK$27.2m0%no data
0.4%
Chen Fei
1,507,680HK$18.8m0%no data
0.00027%
Yiquan Cheng
1,000HK$12.6k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.